ARCHIVES

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Young Early-Stage Patients Can Preserve Fertility

August 28, 2009

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

December 29, 2006

Advocacy: Groups Urge studies Of Environmental Pollutants As Cause Of Cancer

November 5, 1999

FDA Approves Inlyta Pill For Renal Cell Carcinoma

January 27, 2012

Straus asks to “Set Record Straight”

September 2, 1988

Review Of NTP Could Lead To Administrative Changes

April 18, 1980